The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Swiss Med Wkly [Internet]. 2017 Dec. 11 [cited 2025 Oct. 14];147(4950):w14563. Available from: https://www.smw.ch/index.php/smw/article/view/2426